Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Diabetes/Metabolism Research and Reviews|June 13, 2023
Why do some glucose-lowering agents improve non-alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesisGea Ciccarelli, Gianfranco Di Giuseppe, Francesca Cinti, et al.
Minerva Endocrinology|July 5, 2021
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequencesGianfranco DI Giuseppe, Gea Ciccarelli, Chiara M Cefalo, et al.
Frontiers in Clinical Diabetes and Healthcare|February 4, 2026
Use of hybrid closed-loop insulin pump in pancreatogenic diabetes following necrotizing hemorrhagic pancreatitis: a case reportLaura Soldovieri, Gea Ciccarelli, Michela Brunetti, et al.
Molecular Metabolism|June 15, 2023
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetesLaura Soldovieri, Gianfranco Di Giuseppe, Gea Ciccarelli, et al.
Trends in Endocrinology and Metabolism: TEM|May 2, 2026
The role of noradrenergic innervation and β-cell dedifferentiation in diabetesAdriana Avolio, Cassandra Morciano, Shawn Gugliandolo, et al.
Nutrients|January 8, 2025
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk FactorUmberto Capece, Shawn Gugliandolo, Cassandra Morciano, et al.
Cardiovascular Diabetology|December 20, 2024
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectivesCassandra Morciano, Shawn Gugliandolo, Umberto Capece, et al.
Frontiers in Endocrinology|June 16, 2023
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot studySimona Moffa, Teresa Mezza, Pietro Manuel Ferraro, et al.
Iscience|February 26, 2025
Exploring nutraceutical approaches linking metabolic syndrome and cognitive impairmentRebecca Sonnino, Gea Ciccarelli, Simona Moffa, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2023
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide ProductionUmberto Capece, Chiara Pavanello, Francesca Cinti, et al.
Pageof 4